Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review
About this item
Full title
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Abstract
Glioblastoma multiforme (GBM) is one of the most frequent and aggressive primary tumors in the central nervous system, representing more than 60% of all brain tumors in adults. Primary GBM remains incurable with a poor prognosis both for limited therapeutic alternatives and for a high risk of progression or recurrence. In fact, at recur...
Alternative Titles
Full title
Regorafenib beyond the Second Line in Relapsed Glioblastoma: A Case Report and Literature Review
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1159_000524954
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000524954
Other Identifiers
ISSN
1662-6575
E-ISSN
1662-6575
DOI
10.1159/000524954
